Molecular epidemiology and antifungal susceptibility profiles of Aspergillus terreus complex

被引:0
|
作者
Vaezi, A. [1 ]
Badali, H. [1 ]
Meis, J. F. [2 ]
Fakhim, H. [3 ]
Hagen, F. [2 ]
Dannaoui, E. [4 ]
机构
[1] Mazandaran Univ Med Sci, Sch Med, Sari, Iran
[2] Canisius Wilhelmina Hosp CWZ, Nijmegen, Netherlands
[3] Urmia Univ Med Sci, Fac Med, Orumiyeh, Iran
[4] Univ Paris 05, AP HP, Fac Med, Paris, France
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
PP1.006
引用
收藏
页码:S33 / S33
页数:1
相关论文
共 50 条
  • [21] Luliconazole, an alternative antifungal agent against Aspergillus terreus
    Zargaran, M.
    Taghipour, S.
    Kiasat, N.
    Aboualigalehdari, E.
    Rezaei-Matehkolaei, A.
    Mahmoudabadi, A. Zarei
    Shamsizadeh, F.
    JOURNAL DE MYCOLOGIE MEDICALE, 2017, 27 (03): : 351 - 356
  • [22] Molecular epidemiology, antifungal susceptibility and virulence factors of Candida glabrata complex strains in Kayseri/Turkey
    Kaan, Ozge
    Koc, A. Nedret
    Atalay, Mustafa Altay
    Sariguzel, Fatma Mutlu
    MICROBIAL PATHOGENESIS, 2021, 154
  • [23] In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex
    Vaezi, Afsane
    Fakhim, Hamed
    Arastehfar, Amir
    Shokohi, Tahereh
    Hedayati, Mohammad T.
    Khodavaisy, Sadegh
    Rezaei-Matehkolaei, Ali
    Badiee, Parisa
    Hagen, Ferry
    Lass-Floerl, Cornelia
    Dannaoui, Eric
    Meis, Jacques F.
    Badali, Hamid
    MYCOSES, 2018, 61 (02) : 134 - 142
  • [24] Epidemiology of Aspergillus terreus at the University Hospital of Cologne:: molecular typing of environmental and clinical isolates
    Gerlach, S.
    Rueping, M. J. G. T.
    Vehreschild, J. J.
    Fischer, G.
    Cornely, O. A.
    MYCOSES, 2008, 51 (05) : 430 - 430
  • [25] Molecular epidemiology and antifungal susceptibility of Serbian Cryptococcus neoformans isolates
    Arsenijevic, Valentina Arsic
    Pekmezovic, Marina G.
    Meis, Jacques F.
    Hagen, Ferry
    MYCOSES, 2014, 57 (06) : 380 - 387
  • [26] Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of Two In Vitro Methods
    Lyskova, Pavlina
    Hubka, Vit
    Svobodova, Lucie
    Barrs, Vanessa
    Dhand, Navneet K.
    Yaguchi, Takashi
    Matsuzawa, Tetsuhiro
    Horie, Yoshikazu
    Kolarik, Miroslav
    Dobias, Radim
    Hamal, Petr
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [27] Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex
    Al-Hatmi, Abdullah M. S.
    van Diepeningen, Anne D.
    Curfs-Breuker, Ilse
    de Hoog, G. Sybren
    Meis, Jacques F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (04) : 1068 - 1071
  • [28] cyp51A Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex
    Talbot, Jessica J.
    Frisvad, Jens C.
    Meis, Jacques F.
    Hagen, Ferry
    Verweij, Paul E.
    Hibbs, David E.
    Lai, Felcia
    Groundwater, Paul W.
    Samson, Robert A.
    Kidd, Sarah E.
    Barrs, Vanessa R.
    Houbraken, Jos
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
  • [29] Molecular characterization and antifungal susceptibility of Aspergillus, and emergence of uncommon clinical species
    Salah, Husam
    Lackner, Michaela
    Houbraken, Jos
    Theelen, Bart
    Rl, Cornelia Lass-Flo Spacing Diaeresis
    Boekhout, Teun
    Taj-Aldeen, Saad J.
    MEDICAL MYCOLOGY, 2018, 56 : S86 - S86
  • [30] Molecular epidemiology and drug susceptibility profiles of Mycobacterium tuberculosis complex isolates from Northern Ghana
    Acquah, Samuel Kobina Ekuban
    Asare, Prince
    Osei-Wusu, Stephen
    Morgan, Portia
    Afum, Theophilus
    Asandem, Diana Asema
    Danso, Emelia Konadu
    Otchere, Isaac Darko
    Ofori, Linda Aurelia
    Obiri-Danso, Kwasi
    Kock, Richard
    Asante-Poku, Adwoa
    Yeboah-Manu, Dorothy
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 109 : 294 - 303